Malignant pleural mesothelioma.

Suppr

超能文献

作者信息

Pass H I, Pogrebniak H W

机构信息

Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

出版信息

Curr Probl Surg. 1993 Oct;30(10):921-1012. doi: 10.1016/0011-3840(93)90029-g.

DOI:10.1016/0011-3840(93)90029-g

PMID:8404013

Abstract

摘要

相似文献

Malignant pleural mesothelioma.

Curr Probl Surg. 1993 Oct;30(10):921-1012. doi: 10.1016/0011-3840(93)90029-g.

[Malignant pleural mesothelioma: causes, diagnosis and treatment].

Dtsch Med Wochenschr. 1990 Mar 30;115(13):508-13. doi: 10.1055/s-2008-1065040.

[Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma].

Zhongguo Fei Ai Za Zhi. 2010 Oct;13(10):C23-45. doi: 10.3779/j.issn.1009-3419.2010.10.14.

[Treatment of malignant pleural mesothelioma--present status and future view].

Fukuoka Igaku Zasshi. 2008 Apr;99(4):74-9.

Current approach to malignant mesothelioma of the pleura.

Chest. 1995 Jun;107(6 Suppl):332S-344S. doi: 10.1378/chest.107.6_supplement.332s.

[Primary pleural tumors].

Rev Med Suisse Romande. 1973 Feb;93(2):115-31.

Malignant pleural mesothelioma: the standard of care and challenges for future management.

Crit Rev Oncol Hematol. 2011 May;78(2):92-111. doi: 10.1016/j.critrevonc.2010.04.004. Epub 2010 May 13.

[A plea for standardized thoracoscopy in malignant pleural mesothelioma].

Rev Mal Respir. 2001 Dec;18(6 Pt 1):585-9.

The radiology of thoracic malignant mesothelioma.

Crit Rev Diagn Imaging. 1984;20(4):283-310.

[Malignant pleural mesothelioma].

Dtsch Med Wochenschr. 2012 Mar;137(10):481-6. doi: 10.1055/s-0031-1298905. Epub 2012 Feb 28.

引用本文的文献

Expression of cancer-associated molecules in malignant mesothelioma.

Biomark Insights. 2007 May 30;2:173-84.

Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology.

Support Care Cancer. 2008 Dec;16(12):1323-31. doi: 10.1007/s00520-008-0405-5. Epub 2008 Feb 8.

A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction.

Ann Surg Oncol. 1995 May;2(3):214-20. doi: 10.1007/BF02307026.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验